LIVIVO - Search results -

Search results

Result 1 - 10 of total 10

Search options

Article ; Online: Vaping-associated lung illness (VALI) in Canada: a descriptive analysis of VALI cases reported from September 2019 to December 2020.

Baker, Melissa M / Procter, Theresa D / Belzak, Lisa / Ogunnaike-Cooke, Susanna

Health promotion and chronic disease prevention in Canada : research, policy and practice

2022 Volume 42, Issue 1, Page(s) 37–44

Abstract: Introduction: The aim of this study was to explore demographic and clinical characteristics of vaping-associated lung illness (VALI) cases reported in Canada from September 2019 to December 2020; compare the epidemiology of VALI cases in Canada to e- ... ...

Title translation	La maladie pulmonaire associée au vapotage (MPAV) au Canada : une analyse descriptive des cas de MPAV signalés entre septembre 2019 et décembre 2020.
Abstract	Introduction: The aim of this study was to explore demographic and clinical characteristics of vaping-associated lung illness (VALI) cases reported in Canada from September 2019 to December 2020; compare the epidemiology of VALI cases in Canada to e-cigarette or vaping product use-associated lung injury (EVALI) cases in the US; and examine possible explanations for differences between the two countries. Methods: A federal/provincial/territorial task group developed a national outbreak definition, minimum dataset and case report form for identification and surveillance of VALI cases in Canada. Descriptive analysis explored the characteristics and epidemiology of reported VALI cases. Results: Of the 20 VALI cases reported, none resulted in a death. Of all cases, 5 (25%) involved youth aged 15 to 19 years, 10 (50%) adults aged 20 to 49 years and 5 (25%) aged 50 years and older. Sixty percent of patients were men. Half (50%) required breathing assistance. Three-quarters (75%) reported using nicotine-containing vaping products, and 40% reported use of cannabis-containing vaping products; of those who reported frequency of vaping, most (71%) reported vaping daily. VALI cases were reported at a lower prevalence (0.9 per million) than EVALI (8.5 per million). Demographics and vaping behaviour also differed. Conclusion: VALI cases were reported in Canada between September 2019 and December 2020; however, there was a much lower prevalence and they may have been caused by different factors from the EVALI outbreak in the US. The factors influencing VALI in Canada are complex and multifactorial. Research is needed to understand the short- and long-term health effects of nicotine and cannabis vaping.
MeSH term(s)	Adolescent ; Adult ; Aged ; Canada/epidemiology ; Dronabinol ; Electronic Nicotine Delivery Systems ; Humans ; Lung ; Male ; Middle Aged ; Vaping
Chemical Substances	Dronabinol (7J8897W37S)
Language	French
Publishing date	2022-01-17
Publishing country	Canada
Document type	Journal Article
ISSN	2368-738X
ISSN (online)	2368-738X
DOI	10.24095/hpcdp.42.1.06
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

Inter-library loan at ZB MED

Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

Article ; Online: The opioid crisis in Canada: a national perspective.

Belzak, Lisa / Halverson, Jessica

Health promotion and chronic disease prevention in Canada : research, policy and practice

2018 Volume 38, Issue 6, Page(s) 224–233

Abstract: Introduction: This review provides a national summary of what is currently known about the Canadian opioid crisis with respect to opioid-related deaths and harms and potential risk factors as of December 2017.: Methods: We reviewed all public-facing ... ...

Title translation	La crise des opioïdes au Canada : une perspective nationale.
Abstract	Introduction: This review provides a national summary of what is currently known about the Canadian opioid crisis with respect to opioid-related deaths and harms and potential risk factors as of December 2017. Methods: We reviewed all public-facing opioid-related surveillance or epidemiological reports published by provincial and territorial ministries of health and chief coroners' or medical examiners' offices. In addition, we reviewed publications from federal partners and reports and articles published prior to December 2017. We synthesized the evidence by comparing provincial and territorial opioid-related mortality and morbidity rates with the national rates to look for regional trends. Results: The opioid crisis has affected every region of the country, although some jurisdictions have been impacted more than others. As of 2016, apparent opioid-related deaths and hospitalization rates were highest in the western provinces of British Columbia and Alberta and in both Yukon and the Northwest Territories. Nationally, most apparent opioid-related deaths occurred among males; individuals between 30 and 39 years of age accounted for the greatest proportion. Current evidence suggests regional age and sex differences with respect to health outcomes, especially when synthetic opioids are involved. However, differences between data collection methods and reporting requirements may impact the interpretation and comparability of reported data. Conclusion: This report identifies gaps in evidence and areas for further investigation to improve our understanding of the national opioid crisis. The Public Health Agency of Canada will continue to work closely with the provinces, territories and national partners to further refine and standardize national data collection, conduct special studies and expand information-sharing to improve the evidence needed to inform public health action and prevent opioid-related deaths and harms.
MeSH term(s)	Age Factors ; Canada/epidemiology ; Drug Overdose/epidemiology ; Drug Overdose/mortality ; Emergency Medical Services/statistics & numerical data ; Fentanyl/poisoning ; Hospitalization/statistics & numerical data ; Humans ; Naloxone/supply & distribution ; Naloxone/therapeutic use ; Narcotic Antagonists/supply & distribution ; Narcotic Antagonists/therapeutic use ; Narcotics/poisoning ; Opioid-Related Disorders/epidemiology ; Opioid-Related Disorders/mortality ; Prescription Drugs/poisoning ; Risk Factors ; Sex Factors ; Street Drugs/poisoning ; Vulnerable Populations/statistics & numerical data
Chemical Substances	Narcotic Antagonists ; Narcotics ; Prescription Drugs ; Street Drugs ; Naloxone (36B82AMQ7N) ; Fentanyl (UF599785JZ)
Language	French
Publishing date	2018-06-13
Publishing country	Canada
Document type	Journal Article ; Review
ISSN	2368-738X
ISSN (online)	2368-738X
DOI	10.24095/hpcdp.38.6.02
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Inter-library loan at ZB MED

Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

Article ; Online: Prevalence of alcohol use among women of reproductive age in Canada.

Varin, Mélanie / Palladino, Elia / Hill MacEachern, Kate / Belzak, Lisa / Baker, Melissa M

Health promotion and chronic disease prevention in Canada : research, policy and practice

2021 Volume 41, Issue 9, Page(s) 267–271

Abstract: Introduction: Reporting on alcohol use among women of reproductive age in Canada addresses a major gap in evidence.: Methods: We assessed the prevalence of weekly and heavy alcohol consumption among women aged 15 to 54 years by sociodemographic ... ...

Title translation	Fréquence de la consommation d’alcool chez les Canadiennes en âge de procréer.
Abstract	Introduction: Reporting on alcohol use among women of reproductive age in Canada addresses a major gap in evidence. Methods: We assessed the prevalence of weekly and heavy alcohol consumption among women aged 15 to 54 years by sociodemographic characteristics, province of residence and concurrent use of other substance(s) using data from the 2019 Canadian Community Health Survey. Results: Of the target population, 30.5% reported weekly and 18.3% reported heavy alcohol consumption in the past year. Prevalence varied by sociodemographic characteristics, province and substance use. The most notable and significant differences were to do with cannabis use and smoking. Conclusion: This information can guide health care providers in assessing alcohol consumption and in promoting low-risk alcohol drinking to prevent alcohol exposure during pregnancy.
MeSH term(s)	Alcohol Drinking/epidemiology ; Canada/epidemiology ; Female ; Health Surveys ; Humans ; Pregnancy ; Prevalence ; Smoking
Language	French
Publishing date	2021-10-11
Publishing country	Canada
Document type	Journal Article
ISSN	2368-738X
ISSN (online)	2368-738X
DOI	10.24095/hpcdp.41.9.04
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Inter-library loan at ZB MED

Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

Article ; Online: Synthèse des données probantes - La crise des opioïdes au Canada

Lisa Belzak / Jessica Halverson

Promotion de la santé et prévention des maladies chroniques au Canada, Vol 38, Iss 6, Pp 255-

une perspective nationale

2018 Volume 266

Abstract: Introduction. Cette recension offre un panorama à l'échelle nationale de ce que l’on savait, en décembre 2017, au sujet de la crise des opioïdes au Canada, en matière de décès et de méfaits liés à la consommation d’opioïdes et en matière de facteurs de ... ...

Abstract	Introduction. Cette recension offre un panorama à l'échelle nationale de ce que l’on savait, en décembre 2017, au sujet de la crise des opioïdes au Canada, en matière de décès et de méfaits liés à la consommation d’opioïdes et en matière de facteurs de risque potentiels. Méthodologie. Nous avons examiné tous les rapports de surveillance et les rapports épidémiologiques sur les opioïdes destinés au public ayant été publiés par les ministères de la Santé des provinces et des territoires et les bureaux des coroners en chef ou des médecins légistes. Nous avons également examiné les publications de nos partenaires fédéraux ainsi que les rapports et les articles sur le sujet publiés jusqu'à décembre 2017. Nous avons synthétisé les données en comparant les taux de mortalité et de morbidité liés à la consommation d’opioïdes dans les provinces et les territoires aux taux observés à l’échelle nationale afin de déceler d’éventuelles tendances à l’échelle régionale. Résultats. La crise des opioïdes touche toutes les régions du pays, mais certaines sont plus durement atteintes que d’autres. En effet, depuis 2016, les taux de décès et d’hospitalisations apparemment liés à la consommation d’opioïdes sont plus élevés dans les provinces de l’Ouest que sont la Colombie-Britannique et l’Alberta, ainsi qu’au Yukon et dans les Territoires du Nord-Ouest. À l’échelle nationale, la plupart des décès apparemment liés à la consommation d’opioïdes sont survenus chez des hommes et ils ont touché en plus grande proportion les 30 à 39 ans. Les données disponibles laissent penser qu'il existe des différences régionales en matière de résultats de santé en fonction de l'âge et du sexe, en particulier lorsque des opioïdes synthétiques sont en cause. Toutefois, des différences relevant des méthodes de collecte et des exigences relatives à la déclaration des données peuvent jouer sur l’interprétation et la comparabilité des résultats. Conclusion. Ce rapport relève des lacunes en ce qui concerne certaines données et certains domaines, auxquelles il ...
Keywords	opioïdes ; surdose ; crise ; méfaits ; décès ; fentanyl ; Canada ; Medicine (General) ; R5-920
Language	English
Publishing date	2018-01-01T00:00:00Z
Publisher	Agence de la santé publique du Canada
Document type	Article ; Online
Database	BASE - Bielefeld Academic Search Engine (life sciences selection)

Full text online

Full text

Inter-library loan at ZB MED

Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

Article ; Online: Evidence synthesis - The opioid crisis in Canada

Lisa Belzak / Jessica Halverson

Health Promotion and Chronic Disease Prevention in Canada, Vol 38, Iss 6, Pp 224-

a national perspective

2018 Volume 233

Abstract	Introduction: This review provides a national summary of what is currently known about the Canadian opioid crisis with respect to opioid-related deaths and harms and potential risk factors as of December 2017. Methods: We reviewed all public-facing opioid-related surveillance or epidemiological reports published by provincial and territorial ministries of health and chief coroners’ or medical examiners’ offices. In addition, we reviewed publications from federal partners and reports and articles published prior to December 2017. We synthesized the evidence by comparing provincial and territorial opioid-related mortality and morbidity rates with the national rates to look for regional trends. Results: The opioid crisis has affected every region of the country, although some jurisdictions have been impacted more than others. As of 2016, apparent opioid-related deaths and hospitalization rates were highest in the western provinces of British-Columbia and Alberta and in both Yukon and the Northwest Territories. Nationally, most apparent opioid-related deaths occurred among males; individuals between 30 and 39 years of age accounted for the greatest proportion. Current evidence suggests regional age and sex differences with respect to health outcomes, especially when synthetic opioids are involved. However, differences between data collection methods and reporting requirements may impact the interpretation and comparability of reported data. Conclusion: This report identifies gaps in evidence and areas for further investigation to improve our understanding of the national opioid crisis. The Public Health Agency of Canada will continue to work closely with the provinces, territories and national partners to further refine and standardize national data collection, conduct special studies and expand information-sharing to improve the evidence needed to inform public health action and prevent opioid-related deaths and harms.
Keywords	opioid ; overdose ; crisis ; harms ; deaths ; fentanyl ; Canada ; Medicine (General) ; R5-920
Subject code	306
Language	English
Publishing date	2018-06-01T00:00:00Z
Publisher	Public Health Agency of Canada
Document type	Article ; Online
Database	BASE - Bielefeld Academic Search Engine (life sciences selection)

Full text online

Full text

Inter-library loan at ZB MED

Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

Article ; Online: Vaping-associated lung illness (VALI) in Canada

Melissa M. Baker / Theresa D. Procter / Lisa Belzak / Susanna Ogunnaike-Cooke

Health Promotion and Chronic Disease Prevention in Canada, Vol 42, Iss 1, Pp 37-

a descriptive analysis of VALI cases reported from September 2019 to December 2020

2022 Volume 44

Abstract: IntroductionThe aim of this study was to explore demographic and clinical characteristics of vaping-associated lung illness (VALI) cases reported in Canada from September 2019 to December 2020; compare the epidemiology of VALI cases in Canada to e- ... ...

Abstract	IntroductionThe aim of this study was to explore demographic and clinical characteristics of vaping-associated lung illness (VALI) cases reported in Canada from September 2019 to December 2020; compare the epidemiology of VALI cases in Canada to e-cigarette or vaping product use-associated lung injury (EVALI) cases in the US; and examine possible explanations for differences between the two countries. MethodsA federal/provincial/territorial task group developed a national outbreak definition, minimum dataset and case report form for identification and surveillance of VALI cases in Canada. Descriptive analysis explored the characteristics and epidemiology of reported VALI cases. ResultsOf the 20 VALI cases reported, none resulted in a death. Of all cases, 5 (25%) involved youth aged 15 to 19 years, 10 (50%) adults aged 20 to 49 years and 5 (25%) aged 50 years and older. Sixty percent of patients were men. Half (50%) required breathing assistance. Three-quarters (75%) reported using nicotine-containing vaping products, and 40% reported use of cannabis-containing vaping products; of those who reported frequency of vaping, most (71%) reported vaping daily. VALI cases were reported at a lower prevalence (0.9 per million) than EVALI (8.5 per million). Demographics and vaping behaviour also differed. ConclusionVALI cases were reported in Canada between September 2019 and December 2020; however, there was a much lower prevalence and they may have been caused by different factors from the EVALI outbreak in the US. The factors influencing VALI in Canada are complex and multifactorial. Research is needed to understand the short- and long-term health effects of nicotine and cannabis vaping.
Keywords	Medicine (General) ; R5-920
Subject code	360
Language	English
Publishing date	2022-01-01T00:00:00Z
Publisher	Public Health Agency of Canada
Document type	Article ; Online
Database	BASE - Bielefeld Academic Search Engine (life sciences selection)

Full text online

Full text

Inter-library loan at ZB MED

Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

Article ; Online: La maladie pulmonaire associée au vapotage (MPAV) au Canada

Melissa M. Baker / Theresa D. Procter / Lisa Belzak / Susanna Ogunnaike-Cooke

Promotion de la santé et prévention des maladies chroniques au Canada, Vol 42, Iss 1, Pp 42-

une analyse descriptive des cas de MPAV signalés entre septembre 2019 et décembre 2020

2022 Volume 51

Abstract: IntroductionCette étude a eu pour but d’étudier les caractéristiques personnelles et cliniques des cas de maladie pulmonaire associée au vapotage (MPAV) signalés au Canada entre septembre 2019 et décembre 2020, de comparer l’épidémiologie des cas de MPAV ...

Abstract	IntroductionCette étude a eu pour but d’étudier les caractéristiques personnelles et cliniques des cas de maladie pulmonaire associée au vapotage (MPAV) signalés au Canada entre septembre 2019 et décembre 2020, de comparer l’épidémiologie des cas de MPAV au Canada à celle des cas de lésions pulmonaires associées à l’utilisation de produits destinés aux cigarettes électroniques ou au vapotage (EVALI, « e-cigarette or vaping product use-associated lung injury ») aux États-Unis et de tenter d’expliquer les différences entre les deux pays. MéthodologieUn groupe de travail fédéral-provincial-territorial a élaboré une définition nationale d’éclosion, un ensemble de données minimal et un formulaire de déclaration de cas pour l’identification et la surveillance des cas de MPAV au Canada. L’analyse descriptive a porté sur les caractéristiques et l’épidémiologie des cas de MPAV signalés. RésultatsParmi les 20 cas de MPAV signalés, aucun n’a entraîné de décès. Parmi ces cas, 5 (25 %) concernaient des jeunes de 15 à 19 ans, 10 (50 %) des adultes de 20 à 49 ans et 5 (25 %) des adultes de 50 ans ou plus. Soixante pour cent des patients étaient des hommes. La moitié (50 %) ont eu besoin d’assistance respiratoire. Les trois quarts (75 %) ont déclaré avoir utilisé des produits de vapotage contenant de la nicotine et 40 % ont dit avoir utilisé des produits de vapotage contenant du cannabis. Parmi ceux ayant déclaré leur fréquence de vapotage, la plupart (71 %) ont indiqué vapoter quotidiennement. La prévalence des cas de MPAV (0,9 par million) s’est révélée inférieure à celle des cas d’EVALI (8,5 par million). Les caractéristiques personnelles et le comportement de vapotage se sont également révélés différents. ConclusionPlusieurs cas de MPAV ont été signalés au Canada entre septembre 2019 et décembre 2020. Cependant, leur prévalence s’est révélée beaucoup plus faible que celle des cas d’EVALI observés lors de l’éclosion aux États-Unis, et les facteurs en cause ne sont peut-être pas les mêmes. Les cas de MPAV au Canada dépendent ...
Keywords	Medicine (General) ; R5-920
Language	English
Publishing date	2022-01-01T00:00:00Z
Publisher	Agence de la santé publique du Canada
Document type	Article ; Online
Database	BASE - Bielefeld Academic Search Engine (life sciences selection)

Full text online

Full text

Inter-library loan at ZB MED

Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

Article ; Online: Fréquence de la consommation d’alcool chez les Canadiennes en âge de procréer

Mélanie Varin / Elia Palladino / Kate Hill MacaEachern / Lisa Belzak / Melissa M. Baker

Promotion de la santé et prévention des maladies chroniques au Canada, Vol 41, Iss 9, Pp 295-

2021 Volume 299

Abstract: IntroductionLa publication de données sur la consommation d’alcool chez les Canadiennes en âge de procréer comble une lacune importante en matière de données probantes. MéthodologieNous avons analysé, à l’aide des données de l’Enquête sur la santé dans ... ...

Abstract	IntroductionLa publication de données sur la consommation d’alcool chez les Canadiennes en âge de procréer comble une lacune importante en matière de données probantes. MéthodologieNous avons analysé, à l’aide des données de l’Enquête sur la santé dans les collectivités canadiennes de 2019, les taux de consommation hebdomadaire et de consommation excessive d’alcool chez les femmes de 15 à 54 ans en fonction de caractéristiques sociodémographiques, de la province de résidence et de la consommation simultanée d’autres substances. RésultatsParmi la population cible, 30,5 % des femmes interrogées ont fait état d’une consommation hebdomadaire d’alcool et 18,3 % d’une consommation excessive d’alcool au cours des 12 derniers mois. Les proportions variaient en fonction des caractéristiques sociodémographiques, de la province et de la consommation de substances. Les différences les plus notables et les plus significatives étaient liées à la consommation de cannabis et au tabagisme. ConclusionCes renseignements peuvent aider les prestataires de soins de santé à évaluer la consommation d’alcool et à promouvoir une consommation d’alcool à faible risque afin de prévenir l’exposition à l’alcool durant la grossesse.
Keywords	Medicine (General) ; R5-920
Language	English
Publishing date	2021-09-01T00:00:00Z
Publisher	Agence de la santé publique du Canada
Document type	Article ; Online
Database	BASE - Bielefeld Academic Search Engine (life sciences selection)

Full text online

Full text

Inter-library loan at ZB MED

Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

Article ; Online: Prevalence of alcohol use among women of reproductive age in Canada

Mélanie Varin / Elia Palladino / Kate Hill MacaEachern / Lisa Belzak / Melissa M. Baker

Health Promotion and Chronic Disease Prevention in Canada, Vol 41, Iss 9, Pp 267-

2021 Volume 271

Abstract: IntroductionReporting on alcohol use among women of reproductive age in Canada addresses a major gap in evidence. MethodsWe assessed the prevalence of weekly and heavy alcohol consumption among women aged 15 to 54 years by sociodemographic ... ...

Abstract	IntroductionReporting on alcohol use among women of reproductive age in Canada addresses a major gap in evidence. MethodsWe assessed the prevalence of weekly and heavy alcohol consumption among women aged 15 to 54 years by sociodemographic characteristics, province of residence and concurrent use of other substance(s) using data from the 2019 Canadian Community Health Survey. ResultsOf the target population, 30.5% reported weekly and 18.3% reported heavy alcohol consumption in the past year. Prevalence varied by sociodemographic characteristics, province and substance use. The most notable and significant differences were to do with cannabis use and smoking. ConclusionThis information can guide health care providers in assessing alcohol consumption and in promoting low-risk alcohol drinking to prevent alcohol exposure during pregnancy.
Keywords	Medicine (General) ; R5-920
Language	English
Publishing date	2021-09-01T00:00:00Z
Publisher	Public Health Agency of Canada
Document type	Article ; Online
Database	BASE - Bielefeld Academic Search Engine (life sciences selection)

Full text online

Full text

Inter-library loan at ZB MED

Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

Article ; Online: Trends in vaccine-induced immunity to hepatitis B among Canadian street-involved youth.

Huang, Ling / Gilbert, Marie-Line / Rossi, Miriam F / Haase, David / Wright, Judith / Sicard, Nadine / Beaudoin, Carole / Taylor, Darlene / Gratrix, Jennifer / Belzak, Lisa / Wong, Tom / Jayaraman, Gayatri

Journal of urban health : bulletin of the New York Academy of Medicine

2010 Volume 87, Issue 2, Page(s) 337–348

Abstract: In Canada, universal and publicly funded hepatitis B immunization programs have been available since 1998 in all provinces and territories. This present study estimates the proportion of having vaccine-induced immunity to hepatitis B virus (HBV) ... ...

Abstract	In Canada, universal and publicly funded hepatitis B immunization programs have been available since 1998 in all provinces and territories. This present study estimates the proportion of having vaccine-induced immunity to hepatitis B virus (HBV) infection and its associated determinants among street-involved youth aged at 15-24 years old in Canada using the data collected by the Enhanced Surveillance of Canadian Street Youth. Vaccine-induced immunity was identified by blood test results of anti-HBc negative and anti-HBs positive. Of the 4,035 participants included in this study, the overall proportion of those with vaccine-induced immunity to HBV was 51.7% during the study period compared to over 90% among the general adolescent population. The proportion of street-involved youth immunized with HBV vaccine increased from 34.7% in 1999 to 64.4% in 2005. Immunity was higher among females (aOR = 1.43, 1.17-1.75) and among those with a reported history of sexually transmitted infection (aOR = 1.30, 1.03-1.63). The proportion of youth with the immunity decreased as age increased (aOR = 0.78, 0.76-0.81, per year increase). Despite an overall increase in the proportion of Canadian street-involved youth with vaccine-induced immunity to HBV, the proportion was still significantly lower than that observed in the general adolescent population. This highlights the need to improve the access to basic health care and the immunization programs to HBV for street-involved youth through creative outreach programs and other multi-faceted approaches.
MeSH term(s)	Adolescent ; Canada/epidemiology ; Cross-Sectional Studies ; Female ; Hepatitis B Antibodies/isolation & purification ; Hepatitis B Vaccines/therapeutic use ; Hepatitis B virus/immunology ; Hepatitis B, Chronic/epidemiology ; Hepatitis B, Chronic/prevention & control ; Homeless Youth ; Humans ; Male ; Population Surveillance ; Sexually Transmitted Diseases/diagnosis ; Young Adult
Chemical Substances	Hepatitis B Antibodies ; Hepatitis B Vaccines
Language	English
Publishing date	2010-02-20
Publishing country	United States
Document type	Journal Article ; Research Support, Non-U.S. Gov't
ZDB-ID	1435288-6
ISSN	1468-2869 ; 1099-3460
ISSN (online)	1468-2869
ISSN	1099-3460
DOI	10.1007/s11524-009-9428-6
Database	MEDical Literature Analysis and Retrieval System OnLINE

Full text online

Accessible to users with ZB MED library card

In stock of ZB MED Cologne/Königswinter

Ua VI Zs.28: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾

To top

More links

Kategorien

Order via subito

Inter-library loan at ZB MED

More links

Kategorien

Order via subito

Inter-library loan at ZB MED

More links

Kategorien

Order via subito

Inter-library loan at ZB MED

Full text online

More links

Kategorien

Inter-library loan at ZB MED

Full text online

More links

Kategorien

Inter-library loan at ZB MED

Full text online

More links

Kategorien

Inter-library loan at ZB MED

Full text online

More links

Kategorien

Inter-library loan at ZB MED

Full text online

More links

Kategorien

Inter-library loan at ZB MED

Full text online

More links

Kategorien

Inter-library loan at ZB MED

Full text online

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito